Liberty Health Sees Q2 Net Revenue Surge to $10.63 Million
LHS Stock Jumps 20% in Response to Stellar 2nd Quarter Earnings
Liberty Health (CSE: LHS) (OTCQX: LHSIF) released its earnings this morning for the second quarter ended August 31, 2019. The company reported consolidated net revenue for the quarter of $10,627,656, an increase of 378.88% over the $2,219,290 reported for the same period in 2018. Net revenue grew 92.5% quarter over quarter.
Total net revenue for the six months ended August 31, 2019, came in at $16,148,217. This represents an increase of 380.54% compared to the $3,360,408 reported for the same six month period in the previous year.
Thanks to a $14.7 million unrealized gain on biological assets, and the $19.2 million sale of the Chestnut Hill Tree Farm, Liberty Health was able to report net income for the quarter of $22.8 million. This was a huge improvement over last year’s net loss of $5,605,355 for the same period.
Liberty Health’s balance sheet shows the company had $23,884,434 of cash and cash equivalents at the end of Q2 compared to $13,291,426 at the end of the period ended February 28, 2019.
Total current assets and inventory also increased during the quarter to $52.1 million and $22.4 million respectively.
Total liabilities for the quarter came in at $6.4 million after Liberty saw its accounts payables drop from $7 million in the previous quarter to $5.5 million in Q2.
Liberty Health saw its working capital increase by 129% quarter over quarter from $20 million to $45.8 million.
The company associated its strong financial growth on the opening of additional dispensaries and delivery locations throughout the state. Liberty also attributed a large increase in same-store sales as well as a jump in the number of Florida’s registered medical marijuana patients to its earnings success.
“The second quarter of fiscal year 2020 proved to be the largest sales revenue quarter in the history of our Company. Liberty’s continued growth directly ties to the strategic initiatives we have set in place, which has been increasing our Florida production, retail base and delivery footprint along with expanding our product portfolio and brand partnerships. We continue to work on numerous marketing strategies that will complement our expansion plans and simultaneously provide our patients with a more educational, personalized and accessible experience,” said Liberty Health Interim CEO Victor Mancebo.
The company also finished construction on its new 387-acre state-of-the-art LHS 360º Innovation Campus. The facility consists of 300,000 sq ft of greenhouse, processing and production space and has now put Liberty Health in a position as the lowest-cost producer in the state of Florida.
Currently, Liberty Health operates a total of 19 dispensaries across the state of Florida at the following locations:
- North Miami
- Tampa (Hyde Park)
- Tampa (Tetra)
- St. Petersburg
- Boca Raton
- Bonita Springs
- Panama City
- Dania Beach
- Palm Harbor
- Winter Haven
- Merritt Island
- Port St. Lucie
- Orange Park
- Cape Coral
Shares of LHS stock are currently trading at $0.50 per share, up 23.75% on the day. At the time of this writing over 3.75 million shares have changed hands.
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street Soon
Get the full details here so you don’t miss out on the next potential 10 bagger.